drugset / Trial / NCT06538662

An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations

NCT06538662 ↗

Phase 3 Completed 283 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution compared to Vehicle for relieving redness of the eye due to minor eye irritations in pediatric and adult populations.

Timeline

Start
2024-10-07
Primary completion
2025-01-27
Completion
2025-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject FID 123320 Ophthalmic Solution Unknown — Other

Indications